What the agency is buying
by RFPFinder from the notice and attachments; the solicitation governsBARDA seeks contractor(s) to produce vaccine medical countermeasures including influenza vaccines, antigens, and adjuvants for pandemic preparedness and response. This is an IDIQ contract with multiple award types (FFP, FFUP, cost reimbursable) evaluated on best value.
Scope
- Produce influenza vaccines, antigens, adjuvants, and related medical countermeasures for pandemic preparedness.
- Provide manufacturing, regulatory support, clinical/nonclinical studies, and storage for vaccine development and production.
1 signal behind this label (incumbent, repeat winner, short window, brand-name or sole-source language, prior sources sought). Pro shows them with sources.
From USAspending awards and the notice text, recomputed nightly (Oct 7). A signal, not a verdict.
How to get the bid documents
- Download the 25 stored documents below; 1 more open at the source
- Check the submission requirements in the compliance checklist
- Submit by email before 5:00 PM ET on Oct 30
Details
- Place of performance
- Washington, District of Columbia
- Buyer type
- Federal
- Notice type
- Solicitation
- Solicitation no.
- 75A50126R00001_RFP_NPIVS_27
- Category
- Supplies & Equipment
- NAICS
- NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)): 13 open RFPs
- Delivery location
- United States (U.S. facilities preferred) from notice
- Period of performance
- 60-month base period plus one 60-month option period from attachment p.5
- Contract type
- IDIQ (multiple award types: FFP, FFUP, cost reimbursable, hy from attachment p.10
- Evaluation
- Sealed bid, price only (FAR 14) from attachment
- Local presence
- Required
- Amendments
- 2, last Sep 11
- Contact
- Laura Saddison
- Office
- OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE · BARDA - ASPR / DAAPPO / BARDA DCMA
Not stated in the notice: estimated value. Check the bid documents.
Contact details from the source notice. Contact the buyer only about this solicitation.
Key dates
- Amendment 1
- Mon, Aug 17
- Amendment 2
- Fri, Sep 11
Change log
verified Sat, Oct 10 · 12:30 AM ET- Posted · SolicitationThu, Jul 30 · 9:27 PM ET
- Amendment · New version of the notice posted at the sourceMon, Aug 17 · 12:33 PM ET
- Amendment · New version of the notice posted at the sourceFri, Sep 11 · 11:37 AM ET
- Deadline moved · Fri, Oct 30, 2026 · 5:00 PM ET → Fri, Nov 20, 2026 · 5:00 PM ETFri, Sep 11 · 11:37 AM ET
- Deadline moved · Fri, Nov 20, 2026 · 5:00 PM ET → Fri, Oct 30, 2026 · 5:00 PM ETWed, Oct 7 · 12:33 AM ET
- Deadline moved · Fri, Oct 30, 2026 · 5:00 PM ET → Fri, Nov 20, 2026 · 5:00 PM ETThu, Oct 8 · 12:31 AM ET
- Deadline moved · Fri, Nov 20, 2026 · 5:00 PM ET → Fri, Oct 30, 2026 · 5:00 PM ETThu, Oct 8 · 12:32 AM ET
- Deadline moved · Fri, Nov 20, 2026 · 5:00 PM ET → Fri, Oct 30, 2026 · 5:00 PM ETThu, Oct 8 · 12:32 AM ET
- Deadline moved · Fri, Oct 30, 2026 · 5:00 PM ET → Fri, Nov 20, 2026 · 5:00 PM ETFri, Oct 9 · 12:31 AM ET
- Deadline moved · Fri, Nov 20, 2026 · 5:00 PM ET → Fri, Oct 30, 2026 · 5:00 PM ETFri, Oct 9 · 12:32 AM ET
- Deadline moved · Fri, Oct 30, 2026 · 5:00 PM ET → Fri, Nov 20, 2026 · 5:00 PM ETSat, Oct 10 · 12:31 AM ET
- Deadline moved · Fri, Nov 20, 2026 · 5:00 PM ET → Fri, Oct 30, 2026 · 5:00 PM ETSat, Oct 10 · 12:32 AM ET
Report a problem
Notice as published
Request of Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods.
Mandatory Qualification Requirements: To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by:
- Holding a U.S. influenza vaccine license; or 2.
Have developed an influenza vaccine as evidenced by: a. Submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine Please see full solicitation details and proposal submission instructions detailed in attachments 01-19 of this notice.
What this office paid before
USAspending.gov, last 36 months14 awards matched · tier 1: this contracting office (75A501) + PSC AN12. Most recent:
Pro shows every award with the recipient, amount, period and a link to the award record, plus a CSV export. $39/mo.
Sign in or upgradeAwards updated Sat, Oct 10, 2026 · 12:50 AM ET.
This contracting office
4 other open notices from this office · buys mostly Other, Supplies & Equipment
Similar open RFPs
same PSC AN12Listing collected from SAM.gov. Always confirm requirements in the original solicitation before you bid.